Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data

View source ↗

Summary

Clinical trial update examining novel subtypes and multimodal treatment strategies for unresectable combined hepatocellular-cholangiocarcinoma. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zhongda Hospital | Conditions: Combined Hepatocellular-cholangiocarcinoma, Combined Hepatocellular Carcinoma and Cholangiocarcinoma | Status: RECRUITING